Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
12/2003
12/11/2003CA2482639A1 3-substituted quinuclidines and their use
12/10/2003EP1369491A1 Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue
12/10/2003EP1369421A1 Pharmaceutical compositions comprising 2,3-Diaryl-pyrazolo[1,5-B]pyridazine derivatives
12/10/2003EP1369418A1 Quinazoline derivatives
12/10/2003EP1369119A1 Il-12 expression controlling agents
12/10/2003EP1369106A1 Emulsion composition
12/10/2003EP1368473A2 Neurotransmission-associated proteins
12/10/2003EP1368470A2 Transcriptional mediators of blood vessel development and endothelial differentiation
12/10/2003EP1368365A2 C2,5'-disubstituted and n6,c2,5'-trisubstituted adenosine derivatives and their different uses
12/10/2003EP1368364A1 C2, 8-disubstituted adenosine derivatives and their different uses
12/10/2003EP1368357A1 Tricyclic quinolinone and tricyclic quinoline as androgen receptor modulator compounds
12/10/2003EP1368355A2 Substituted pyrazolopyrimidines and thiazolopyrimidines
12/10/2003EP1368354A1 Modulators of chemokine receptor activity
12/10/2003EP1368343A1 1-(2-methoxybenzyl)-3-benzhydrylpiperazines as tachykinin antagonists
12/10/2003EP1368324A1 Quinazolines as mmp-13 inhibitors
12/10/2003EP1368320A1 Substituted 2-oxy-3,5-dicyano-4-aryl-6-aminopyridines and use thereof
12/10/2003EP1368319A1 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use as adenosine receptor-selective ligands
12/10/2003EP1368314A1 N-4-piperidinyl compounds as ccr5 modulators
12/10/2003EP1368308A1 Cannabinoid receptor ligands
12/10/2003EP1368296A1 Fluorinated trienes and their use as rxr modulators
12/10/2003EP1368060A1 Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases
12/10/2003EP1368054A2 Using neural thread proteins to treat tumors and other hyperproliferative disorders
12/10/2003EP1368037A2 Estrogen replacement therapy
12/10/2003EP1368031A2 Method of treating of demyelinating diseases or conditions
12/10/2003EP1368029A2 Method and composition for rejuvinating cells, tissues, organs, hair and nails
12/10/2003EP1368026A1 Use of active substance combinations from alpha lipoic acid and substances that absorb light in the uv-a and/or uv-b range for use in the treatment and/or prophylaxis of undesired cutaneous pigmentation
12/10/2003EP1367998A2 Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies
12/10/2003EP1367989A1 Use of a mixture designed to reduce secretion of sebum in a cosmetic or dermatological composition
12/10/2003EP1367987A2 Use of active-ingredient combinations consisting of alpha-lipoic acid and dermatologically compatible substances that absorb light in the uv-a and/or uv-b wavelength range(s), for producing cosmetic or dermatological preparations
12/10/2003EP1367982A2 Hair follicle neogenesis by injection of follicle progenitor cells
12/10/2003EP1367899A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
12/10/2003EP1367886A2 Scce modified transgenic mammals and their use as models of human disease
12/10/2003EP1039916B1 Use of at least one fucane for the manufacture of a medicament for the treatment of periodontal pathologies
12/10/2003EP0970046B1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
12/10/2003EP0966276B1 Use of beta-3 adrenergic receptor agonists for preparing wound-healing pharmaceuticals
12/10/2003EP0666914B1 Novel p-selectin ligand protein
12/10/2003CN1461310A ANtibodies that bind human interleukin-18 and methods of making and using
12/10/2003CN1461219A Non-sedating barbiturate compounds as neuroprotective agents
12/10/2003CN1461214A Compositions for improving skin environment and clothes thereof
12/10/2003CN1460519A Application of boningmycin for curing psoriasis and seborrheic dermatitis
12/10/2003CN1460512A Water-soluble propolis liquor and its preparation method
12/10/2003CN1460499A Wulongqubai capsule
12/10/2003CN1460479A New application of lactose derivative
12/10/2003CN1460466A Multifunctional face-beautifying Chinese medicine face mask
12/10/2003CN1130358C Imidzzole compounds and preparing method and application thereof
12/10/2003CN1130355C Thienyl-, furyl-, pyrrolyl-and biphenylsulfonamides and derivatives thereof modulate activity of endothelin
12/10/2003CN1130223C Pharmaceutical formulation containing growth hormone, amino acid and non-ionic detergent
12/10/2003CN1130211C Method for preparing medicine of burn and scald
12/10/2003CN1130201C Synergistic gold-containing compositions
12/10/2003CN1130195C Nanoemulsion based on ethoxylated fatty ether or ethoxylated fatty ester, and use thereof
12/10/2003CN1130171C Stretchable hood utensil containing stretchable adhesive matrix at least in moisture state
12/09/2003US6660839 Tumor necrosis related receptor, TR7
12/09/2003US6660760 Heterocyclic aromatic compounds useful as growth hormone secretagogues
12/09/2003US6660759 4.5-diaryloxazole compounds with prostaglandin I2 (PGI2) agonistic activity
12/09/2003US6660744 Pyrazolopyrimidines as therapeutic agents
12/09/2003US6660738 Such as (3R,5S)-1-pyrimidin-2-yl-5-(2,4,5-trifluoro-benzyloxymethyl)-pyrrolidine-3 -thiol trifluoro-acetate useful as inhibitors of metalloproteases for treating diseases associated with vasoconstriction
12/09/2003US6660732 Ureas and thioureas inhibit production of cytokines
12/09/2003US6660305 Useful for the treatment of vitiligo; topically applying ethanol, an extract of human placenta, and calcium chloride
12/09/2003US6660304 Method of treating prickly heat
12/09/2003US6660252 Low emulsifier multiple emulsions
12/09/2003US6660251 Galenic formulation containing biotin
12/09/2003US6659282 Antiinflammatory lipoxing derivatives
12/09/2003CA2387284C Chinese herbs extract
12/09/2003CA2376833C Oxidatively stable, long-chain ethyl ester emollients
12/09/2003CA2301649C Burn treatment composition
12/09/2003CA2272880C Composition and method for reducing stinging in skin
12/09/2003CA2266925C Skin care compositions containing an amide and retinol or retinyl ester
12/09/2003CA2202075C Analogs of keratinocyte growth factor, nucleic acids encoding such analogs, processes of making and methods of using
12/09/2003CA2140247C Novel vitamin d analogues
12/04/2003WO2003100438A1 Assays for modulators of asparaginyl hydroxylase
12/04/2003WO2003100087A2 Regulation of novel human asparagine-hydroxylases
12/04/2003WO2003100033A2 ANTI-αvβ6 ANTIBODIES
12/04/2003WO2003100008A2 Neutralizing human anti-igfr antibody
12/04/2003WO2003099839A1 Modulators and inhibitors of fibroblast growth factor receptor 5_polypeptides and gene expression thereof.
12/04/2003WO2003099836A1 C-aryl glucoside sglt2 inhibitors and method
12/04/2003WO2003099827A1 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
12/04/2003WO2003099823A2 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
12/04/2003WO2003099820A1 Pyrazolo-pyrimidine aniline compounds
12/04/2003WO2003099819A2 Oxophenyl-cyclohexyl-propanolamine derivatives, production and use thereof in therapeutics
12/04/2003WO2003099813A1 Novel physiolgically active substances
12/04/2003WO2003099811A1 Kinase inhibitors
12/04/2003WO2003099808A1 Substituted heterocyclic compounds and methods of use
12/04/2003WO2003099807A1 New indolylpiperidine derivatives as potent antihistaminic and antiallergic agents
12/04/2003WO2003099805A1 Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions
12/04/2003WO2003099796A1 Protein kinase inhibitors
12/04/2003WO2003099781A2 METHODS FOR THE IDENTIFICATION OF IKKα FUNCTION AND OTHER GENES USEFUL FOR TREATMENT OF INFLAMMATORY DISEASES
12/04/2003WO2003099773A1 Ccr9 inhibitors and methods of use thereof
12/04/2003WO2003099772A1 Phenylcyclohexylpropanolamine derivatives, preparation and therapeutic application thereof
12/04/2003WO2003099771A2 Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
12/04/2003WO2003099765A1 β-ALANINE DERIVATIVE AND USE THEREOF
12/04/2003WO2003099752A1 Gingerol analogues and use thereof
12/04/2003WO2003099337A2 Inclusion complexes of rosiglitazone
12/04/2003WO2003099334A1 Topically applicable pharmaceutical preparation
12/04/2003WO2003099327A1 Parakeratosis inhibitor, pore-shrinking agent and skin preparation for external use
12/04/2003WO2003099323A1 Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases
12/04/2003WO2003099295A1 Dual dispenser for aesthetically acceptable delivery of anhydrous skin treatment compositions
12/04/2003WO2003099284A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain
12/04/2003WO2003099279A1 Combination of a dpp iv inhibitor and a cardiovascular compound
12/04/2003WO2003099278A1 Ophthalmological use of roflumilast for the treatment of diseases of the eye
12/04/2003WO2003099271A1 Use of diuretics for treating swellings
1 ... 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 ... 1065